Walgreens’ stock had a disappointing performance during the course of the year but there as been some recovery after a decent result. The company delivered an all-around beat in the last quarter. As a result of construction and supply-side delays, the pace of Walgreen is slower. In the quarter pharmacy performance benefitted from the improved trends from maintenance medications and seasonal scripts. Walgreens is making consistent progress and important strides to build the U.S. Healthcare segmen ....
